Recent Analyst Forecasts and Stock Ratings
Lexeo Therapeutics, Inc. Common Stock FAQ's
Lexeo Therapeutics, Inc. Common Stock has been rated by research analysts at Robert W. Baird in the past 90 days.
Lexeo Therapeutics, Inc. Common Stock has been rated by research analysts at Robert W. Baird in the past 90 days.